Last Updated on May 5, 2026 by editor
RI-StatewideToplinesVarious reports from 2017 to 2023 covered how lawmakers across 17 states were introducing legislation to legalize recreational marijuana, emboldened by the tax windfalls Colorado ($200M) and Washington ($256M) had generated and by a wave of successful ballot measures in California, Massachusetts, Maine, and Nevada.
The legislative push reflected a significant strategic evolution within the cannabis reform movement, as advocates and policymakers pivoted from citizen-led ballot initiatives toward institutionalized, legislature-driven statutory frameworks — a trajectory that closely mirrored the earlier decriminalization and medicalization pathway that medical cannabis had carved through state assemblies in the preceding decade.
This shift carried profound implications for medical marijuana access , and some hard-fought battles that were won, as legislative channels offered a more structured mechanism for embedding clinical safeguards, physician-oversight protocols, and evidence-based therapeutic guidelines directly into law — moving cannabis-as-medicine closer to the regulatory legitimacy it required to be seriously integrated into mainstream pharmacological and rehabilitation practice.
Rhode Island poll: Our Public Policy Polling survey showing 59% of Rhode Islanders supported legalization versus 35% opposed.
Useful Readings & References
Clinical Research & Authority Sources
- NIH/PubMed — CBD Use Among OUD Patients in Treatment (Mount Sinai, 2024) A peer-reviewed survey of 550 patients at the Addiction Institute of Mount Sinai, finding 23% were already using CBD independently for anxiety, pain, sleep, and withdrawal symptoms — with reported improvements across all four. https://pmc.ncbi.nlm.nih.gov/articles/PMC11253449/
- Project CBD — Cannabis & Addiction Resource Hub A well-sourced, science-focused nonprofit resource aggregating clinical studies on CBD’s role in addiction recovery across opioids, alcohol, and nicotine. Good for readers who want to go deeper into the primary literature. https://projectcbd.org/medical-conditions/addiction/
- UC San Diego — Center for Medicinal Cannabis Research (CMCR) The leading US academic body funding and coordinating cannabis clinical research, including addiction-related studies. Provides ongoing trial updates, researcher commentary, and policy briefings. https://www.cmcr.ucsd.edu/
- GoodRx — Cannabis & CBD in Addiction Recovery (Clinician-Reviewed) A practical, well-referenced overview written for patients, covering what’s known and unknown about cannabis-based interventions in substance use disorder — with a full reference list of primary studies. https://www.goodrx.com/conditions/substance-use-disorder/cannabis-cbd-for-addiction-recovery
Law, Policy & Federal Regulation
- The White House — Executive Order on Increasing Medical Marijuana & CBD Research (Dec 2025) The Trump administration’s December 2025 executive order directing federal agencies to expand medical cannabis research infrastructure and develop a regulatory framework for hemp-derived CBD products. Essential reading for understanding the current US federal legal landscape. https://www.whitehouse.gov/presidential-actions/2025/12/increasing-medical-marijuana-and-cannabidiol-research/
- US Department of Justice — DEA Rescheduling Announcement (2025) The official DOJ announcement placing FDA-approved cannabis products in Schedule III, with an administrative hearing scheduled for June 2026 on broader rescheduling. The most current federal legal development directly affecting medical cannabis research and patient access. https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana
Advocacy Organizations
- Drug Policy Alliance — Marijuana Justice Coalition A broad coalition of over 100 organizations — including medical, racial justice, and harm reduction groups — lobbying Congress for comprehensive cannabis reform. Their work sits at the intersection of drug policy, racial equity, and patient access. https://drugpolicy.org/mjc/
- Marijuana Policy Project (MPP) The US’s largest cannabis law reform organization, with a track record of passing 15 medical cannabis laws across states. Their policy library covers patient access, clinical research barriers, and federal reform — directly relevant to the “access for rehabilitation patients” dimension of this topic. https://www.mpp.org/about/
Activist & Volunteer Work / Personal experiences
- Last Prisoner Project A nonprofit doing direct intervention and advocacy work for people incarcerated for cannabis offenses — including individuals sentenced under laws that criminalized the very substance now being studied as a rehabilitation tool. They’ve cleared over 250,000 cannabis offenses and put $3.8 million directly into the hands of those harmed by criminalization. A useful counterweight that grounds the medical conversation in the human cost of prohibition. https://www.lastprisonerproject.org/
- Medical cannabis in Drug Withdrawal – Medical cannabis — shows real but nuanced promise as an adjunct tool in drug detox and rehabilitation, with the strongest evidence emerging around opioid craving reduction and alcohol withdrawal management. This article breaks down the THC vs. CBD distinction, reviews the clinical trial landscape across different substances, addresses where cannabis is counterproductive, and includes firsthand clinical observations on how it plays out in practice.
- I turned to medical cannabis to treat my ADHD on Reddit